Commencement of Atorvastatin and Ezetimibe immediately in patients presenting with acute coronary syndrome
Sallam, Mohammed Hassan, Hossameldin Connolly, Derek Rahman, Mohammed Shamim
Sallam, Mohammed
Hassan, Hossameldin
Connolly, Derek
Rahman, Mohammed Shamim
Citations
Altmetric:
Affiliation
Sandwell and West Birmingham NHS Trust
Other Contributors
Publication date
2024-11-12
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Lipids are implicated in the development of coronary atherosclerosis. Achieving a significant reduction in lipid levels remains a crucial aspect of secondary prevention following an acute coronary syndrome event. Novel lipid-lowering therapies now provide clinicians with a variety of therapeutic strategies to choose from and tailor to individual patient needs. This review focuses on evidence supporting the importance of early and intensive lipid-lowering therapy use in patients presenting with acute coronary syndrome, specifically addressing data relating to atorvastatin and ezetimibe use in this high-risk cohort of patients.
Citation
allam M, Hassan H, Connolly D, Rahman MS. Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome. Eur Cardiol. 2024 Nov 12;19:e22. doi: 10.15420/ecr.2024.06
Type
Article